Navigation Links
USDA awards enhance the nutritional quality of food aid products

WASHINGTON, Sept. 30, 2010 The USDA's National Institute of Food and Agriculture awarded nearly $3.8 million to develop healthier food products for humanitarian assistance programs.

"The United States is a major supplier of food aid, feeding millions of people around the world who are suffering during emergency situations," said Roger Beachy, director of USDA's National Institution of Food and Agriculture (NIFA). "These projects will improve the nutritional quality of food aid products these people depend on for survival."

NIFA's Food Aid Nutrition Enhancement Program (FANEP) supports the development and field testing of new ready-to-use foods, fortified blended foods, high-energy foods, micronutrient powders or other food products designed to improve the nutritional delivery and functional form of humanitarian food assistance. Projects funded by FANEP may also field test existing food products that have not yet been approved for use in food aid programs.

Fiscal Year 2010 awards were made to Johns Hopkins University (JHU) and international non-profit PATH. JHU received $2,729,000 to introduce and test three specially formulated foods for children ages 6-24 months in Bangladesh, where childhood under-nutrition is especially prevalent. PATH received $1 million to test their product Ultra Rice in Burundi. Ultra Rice is a rice fortification technology that has been shown to affordably increase micronutrients within manufactured rice.


Contact: Jennifer Martin
United States Department of Agriculture -- Research, Education and Economics

Page: 1

Related biology news :

1. NIH awards Muscular Dystrophy Cooperative Research Center grants
2. NINDS awards new Udall Centers for Parkinsons Disease Research
3. Penn Vet announces $100,000 winners of 2010 World Leadership Award and Student Inspiration Awards
4. MARC Travel Awards announced for the 2010 SACNAS Annual Meeting
5. MARC Travel Awards announced for the 2010 Biomedical Engineering Society Annual Meeting
6. MARC Travel Awards announced for the 2010 Society for Leukocyte Biology Meeting
7. MARC Travel Awards announced: The 2010 Società Italiana di Patologia XXX National Congress
8. Top cancer specialists receive ESMO awards
9. ORNL wins 2 awards for sustainability program
10. Novartis awards 2010 Prizes for Immunology in recognition of outstanding contributions to immunology in medical research
11. Iowa State awards grants to develop health, energy and research technologies
Post Your Comments:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... ON (PRWEB) , ... June 23, 2016 , ... STACS ... DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as ... the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
Breaking Biology Technology: